The benefits of the breast cancer mammography screening are often overestimated, while harms are underestimated, reports Harvard Medical School in a blog post.
In a JAMA Insights article, published on May 1, co-authors Keating and Pace summarize the current state of breast cancer screening in the U.S. The authors note that, despite the fact that the U.S. Preventive Services Task Force in 2009 (USPSTF) changed its recommendation for mammography to every two years for women aged 50 to 74 instead of annually beginning at age 40, there has been little change in U.S. screening practices.
Get the full story at Harvard Medical School.
